In addition, we found that SNP rs2237051 (Ile to Met) in the exon region of EGF is associated with an increased risk of gastric cancer (particularly for the intestinal type) and another SNP rs3733625 in the 3′UTR is associated with a decreased risk of gastric cancer (particularly for the intestinal type). The gene discussed is EGF; the disease is gastric cancer.